Advancing How We Learn from Biodesign to Mitigate Risks with Next-Generation Genome Engineering

In the last decade, the unprecedented simplicity and flexibility of the CRISPR-Cas system has made it the dominant transformative tool in gene and genome editing. However, this democratized technology is both a boon and a bane, for which we have yet to understand the full potential to investigate an...

Full description

Bibliographic Details
Main Authors: Paul E. Abraham, Jessy L. Labbé, Amber A. McBride
Format: Article
Language:English
Published: American Association for the Advancement of Science 2020-01-01
Series:BioDesign Research
Online Access:http://dx.doi.org/10.34133/2020/9429650